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Executive Summary 
A Multiple Sclerosis (MS) Education Module to Promote Patient Activation and Efficacy 
Problem 
 It is estimated that over 572,000 people in the United States have MS, with 
approximately 200 new cases being diagnosed each week (National Multiple Sclerosis Society, 
n.d.).  In order to increase self-care, reduce the level of impairment, and ultimately, cost to the 
healthcare system, the consistent use of a targeted educational intervention should be 
implemented.  The problem statement describing the capstone project was: Will the 
implementation of a structured educational program enhance the knowledge of MS patients and 
their caregivers regarding the disease process of MS, resulting in increased patient activation and 
self-efficacy? 
Purpose 
 The purpose of the project was to examine whether an educational module related to the 
disease process of MS would improve patient activation and self-efficacy of MS patients and 
their caregivers with the goal being the creation of a uniform curriculum that can provide 
patients with enhanced knowledge of MS as well as an increased confidence related to self-care 
activities. 
Goal 
 The goal of this project was to determine the impact of patient education on self-efficacy 
and patient activation on MS patients. 
Objectives 
 Project objectives included the provision of a learning opportunity for MS patients to 
enhance their knowledge of the disease process and self-efficacy. Additionally, the project 
created a sustainable, reproducible patient education program, which would hopefully lead to an 
improvement in self-efficacy and patient activation, and potentially show improvement in their 
quality of life and delay disability. 
Plan 
 In order to assess the effectiveness of the educational intervention that was introduced in 
this project, a pre- and post-intervention design was utilized, comparing the scores that were 
achieved on both the Multiple Sclerosis Knowledge Questionnaire (MSKQ) and the Patient 
Activation Measure (PAM). The MSKQ has been found to be a reliable and valid method for the 
assessment of knowledge in regards to MS symptomatology, treatment options, and prognosis 
(Giordano et al., 2010). The PAM has been shown to be a valid and highly reliable method for 
measuring patient activation (Hibbard, Stockard, Mahoney, & Tusler, 2004). 
 
Outcomes and Results 
 The results from the study indicate that the educational intervention was effective in 
increasing the level of knowledge participants possessed with respect to the symptoms of MS. 
Based on the data obtained, the effect size between the pre- and post-test conditions in regards to 
the PAM, the Cohen’s d was 0.49, which is considered to be a medium effect size (Polit, 2010).  
The difference between the pre- and post-test conditions in regards to the MSKQ scores provided 
a Cohen’s d of 1.37, which is considered to be a relatively large effect size.  Such a result would 
suggest that the educational intervention program used in the current study was effective in 
expanding the knowledge base of the participants in regards to MS.   
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A Multiple Sclerosis Education Module to Promote Patient Activation and Efficacy 
 Multiple sclerosis (MS) is a debilitating disease with symptoms such as numbness and 
weakness in the limbs, cerebral lesions leading to blurred vision, bowel dysfunction, and even 
affective disorders such as depression and anxiety.  While the onset of the disease may not 
inhibit the movements or result in a severe disability, by the time a patient has lived with MS for 
20 years, the majority of individuals are no longer fully ambulatory (MS Coalition, 2014).  One 
method to effectively treat symptoms are programs designed to teach patients strategies to deal 
with symptomology, however, these educational programs are not uniform in the delivery of 
information presented and frequently do not provide patients with pathophysiology of the disease 
process.  Additionally, the programs are not offered routinely upon diagnosis of the disease.  
Despite extensive research, it is difficult to verify the exact number of people with a 
definitive diagnosis of MS.  There is currently no national or global registry for MS cases, 
therefore, figures are only estimates.  It is estimated that more than 572,000 people in the United 
States have MS, with approximately 200 new cases being diagnosed each week (National 
Multiple Sclerosis Society, n.d.).  According to the National Multiple Sclerosis Society (NMSS), 
MS is the most widespread disabling neurological condition of young adults in the US and 
worldwide.  Compared with other chronic conditions, MS ranks second only to congestive heart 
failure in terms of costliness (National Multiple Sclerosis Society, n.d.).  Additionally, few 
current articles speak to disease education.     
 The prevalence of MS suggests that it is a global epidemic.  Worldwide, it is estimated 
that MS affects 30 in 100,000 individuals; in the United States, the prevalence is estimated at 135 
in 100,000; more than the worldwide prevalence, and places the United States at the top of the 
global rates of prevalence (Fox, 2010).  In the United States, the annual mean cost, including 
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patient care, alterations to home and vehicle, medications, purchase of special equipment, and 
loss of earnings, was $69,000 per patient in 2010.  This figure translates to a national annual cost 
of $28 billion in the United States (National Multiple Sclerosis Society, n.d.) and a mean lifetime 
cost of $3.4 million per patient (Kobelt, Berg, Atherly, & Hadjimichael, 2006).  There is 
significant evidence in primary care that the promotion of health care self-management programs 
can improve elements of health status, while reducing costs in populations with diverse chronic 
diseases (Lorig, Sobel, Stewart, Brown, Bandura, Ritter, Gonzales, Laurent & Holman, 2008). 
Problem Recognition and Definition 
 Presently, there are a variety of programs that have been introduced in order to educate 
both patients and healthcare professionals on the various treatment options available for 
symptom management.  Although some programs appear to be beneficial, there remains a need 
for a more personal and comprehensive educational curriculum that could ideally, be 
implemented in local practices.  The optimal educational program would include an emphasis on 
the pathophysiology of the disease (including brain anatomy and immunology), symptom 
expectations, treatment options, and prognosis.  Through the involvement of patients as well as 
caregivers, a program could be developed and implemented. 
 A great number of the MS programs currently in use involve outpatient education on 
topics such as exercise, nutrition, lifestyle, stress management, and responsible health behavior 
(Ennis, Thain, Bogglid, Baker, & Young, 2006).  There are currently other programs focusing on 
education regarding disease-modifying therapies for patients who have been newly diagnosed 
(Solari et al., 2010).  Despite the target demographic of the programs previously implemented, 
the underlying theme, which seems to be the most beneficial in terms of patient outcomes and 
quality of life, is the role that patient activation, self-efficacy, and education play in the treatment 
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and management of MS symptoms.  Similar to self-efficacy, patient activation is defined as the 
knowledge, skills and confidence essential to managing one’s own health and healthcare (Greene 
& Hibbard, 2012).  A search of the literature related to patient education suggested that increased 
knowledge may decrease the likelihood of unrealistic expectations of patients in regards to their 
disease processes (Coulter, Entwistle, & Gilbert, 1999).  Additionally, patient education may 
provide the confidence patients need to participate in treatment choices (Kasper, Kopke, 
Muhlhauser, & Heesen, 2006; Greene & Hibbard, 2012), which may ultimately impact 
adherence, symptom management, the course of the disease, as well as the quality of life 
(Heesen, Kasper, Kopke, & Muehlhauser, 2007).  With these benefits in mind when creating an 
educational intervention, the patient can remain the priority.  
Statement of Purpose 
The program developed for this capstone project was aimed to educate newly diagnosed 
MS patients regarding the pathophysiology of the disease process, current treatments, symptom 
management and prognosis, resulting in increased knowledge regarding the disease process and 
therefore, more self-efficacy and confidence to participate in their care.  As early as 2003, the 
Institute of Medicine looked at programs to change patients’ behavior by increasing the patients’ 
self-efficacy and knowledge.  The thought behind these programs claimed improved behaviors 
were expected to lead to better disease control, which should lead to better patient outcomes and 
reduced utilization of healthcare services, particularly preventable emergency room and 
hospitalizations, and ultimately to reduce costs (Pearson, Mattke, Shaw, Ridgely, & Wiseman, 
2007).  
The program utilized research supporting previous educational interventions promoting 
self-management practices, which have been shown to improve self-efficacy, health status, and 
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reduce the burden placed on hospitals for the care of patients with chronic and progressive 
diseases (Lorig et al., 2001).  Therefore, the purpose of this capstone project was to examine if 
the implementation of a structured educational program enhanced the knowledge of MS patients 
and their caregivers regarding the disease process of MS resulting in increased patient activation 
and self-efficacy. Similar to self-efficacy, patient activation is defined as the knowledge, skills, 
and confidence essential to managing one’s own health and healthcare (Greene & Hibbard, 
2012). 
The main objective of the MS educational program was to provide education, which 
would enhance the scope of knowledge, encourage self-management and treatment, in 
anticipation of improved clinical outcomes.  By providing quality education, presented through a 
simple approach, a better understanding of the disease process can be gained (Lillyman & 
Farquharson, 2013).  Education may increase the likelihood of realistic expectations of the 
disease process and therefore, decrease fear, allowing patients to experience fewer exacerbations 
and improve symptom management (Coulter, Entwistle, & Gilbert, 1999). 
Statement of Problem 
 Newly diagnosed MS patients are usually uneducated regarding their disease process, 
which may cause anxiety and poor coping skills, leading to poor self-care practices.  Currently, 
most healthcare systems have no provision for patient education regarding the very complicated 
disease of MS.  With current physician visit times averaging 21 minutes for a specialty practice 
(Shaw, Davis, Fleischer, & Feldman, 2014), an independent patient education program is 
necessary in order to provide adequate disease information to patients.  The ideal educational 
program would include an emphasis on the pathophysiology of the disease (including brain 
anatomy and immunology), symptom expectations, treatment options, and prognosis. 
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 A great number of MS programs described in the literature involve outpatient education 
on topics such as exercise, nutrition, lifestyle, stress management, and responsible health 
behaviors (Ennis, Thain, Bogglid, Baker, & Young, 2006).  The role of proper disease education 
appears to be lacking.  Furthermore, the underlying theme, which would seem to be the most 
beneficial in terms of patient outcomes and quality of life, the role of patient activation and self-
efficacy, is missing from most programs. 
 Literature pertaining to patient education suggests that increased knowledge of the 
symptoms and prognosis of a disease may decrease the likelihood of unrealistic expectations of 
patients in regards to their disease process (Coulter, Entwistle, & Gilbert, 1999).  Additionally, 
patient education may provide the confidence patients need to participate in treatment choices 
(Kasper, Kopke, Muhlhauser, & Heesen, 2006; Greene & Hibbard, 2012), which may ultimately 
have an impact on adherence, symptom management, the course of the disease, as well as the 
quality of life (Hessen et al., 2007). 
 There is significant evidence in primary care settings that the promotion of health 
management programs can improve the health status of patients, while at the same time reducing 
costs associated with the management of chronic diseases such as MS (Lorig et al., 2001). By 
keeping the following findings from research while creating an educational intervention, the 
patient remains the priority: 
● Patient education is an important responsibility for any disease, but especially important 
with MS, where the symptoms are so varied. 
● Knowledge of problematic symptoms helps to encourage early treatment with the 
potential to reverse symptoms before they become permanent. 
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● Knowledge of realistic expectations allows patients to approach the disease with a 
reasonable attitude, with a positive outlook, and without unnecessary fears of the 
unknown. 
● Knowledge of others’ coping skills with regard to various problems that may arise with 
MS allows for maximal functioning within the disability. 
● Promotion of understanding from family and friends prevents unnecessary suffering and 
establishes a valuable support system (Lorig et al., 2008). 
PICO Statement 
This project is an evidence-based practice (EBP) project in which a quality improvement 
plan, program evaluation, or simple educational or standard of care intervention will be 
completed.  In most cases, a simple pre-test and post-test evaluation will assess the effect of the 
intervention.  The project will be internal to an agency and will inform the agency of issues 
regarding health care quality, cost, and patient satisfaction.  The results of this project are not 
meant to generate new knowledge or be generalizable across settings but rather seek to address a 
specific population, at a specific time, in a specific agency.  These projects translate and apply 
the science of nursing to the greater healthcare field.  Projects utilize the acronym “PICO”, rather 
than stating a formal research hypothesis.  The acronym stands for:  Population or Disease (P), 
Intervention or Issue of Interest (I), Comparison group or Current Practice (C), and Outcome (O) 
and is usually framed as a question (Melnyk and Fineout-Overholt, 2011, p. 31). 
 Based on the needs assessment of the chosen population, the question about the 
population, intervention, comparison, and outcome was developed: 
   7 
 
 
 
Will the implementation of a structured educational program enhance the knowledge of MS 
patients and their caregivers regarding the disease process of MS resulting in increased patient 
activation and self-efficacy? 
P: Patients currently diagnosed with MS receiving treatment at a neurological clinic. 
I: The establishment of a formal, structured, educational curriculum, which will include 
pathophysiology, symptom expectations, treatment of symptomatology, as well as the disease 
process and prognosis. 
C: Currently, there are no structured programs within the proposed location. 
O: The enhancement of knowledge in patients regarding the disease process of MS and the 
increased confidence related to self-care activities following the educational intervention. 
Variables 
 The independent variable for the current research project was the educational curriculum 
given to the patients, caregivers, and staff who elected to take part in the project.  The 
information presented was based on the format recommended by the NMSS, which included 
modules on pathophysiology, realistic symptom expectation, treatment options, and the 
prognosis of the disease. 
 The project also contained two dependent variables, which were composed of the 
knowledge level of the patients and participants regarding MS, as well as the confidence the 
patients had related to the self-care activities and self-efficacy that is hypothesized to accompany 
structured educational interventions (Rigby Domenech, Thornton, Tedman, & Young, 2003).  
The Multiple Sclerosis Knowledge Questionnaire and the Patient Activation Measure, 
respectively were used to measure these variables.  These particular variables were selected as 
the impact they potentially have on the quality of life, which has been suggested as a key 
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identifying factor in the ability of a patient to cope with the often-debilitating effects of MS 
(Taraghi & Ilali 2010).  These two dependent variables were assessed individually in order to 
determine if there was a correlation between the amount of knowledge gained through the 
educational intervention and the level of self-confidence present to assume the increased 
responsibility associated with self-care of the symptoms associated with the chronic disease. 
 
 Figure 1. PICO Variables 
Project Significance, Scope, and Rationale 
 There is a significant gap in the literature focusing on disease process knowledge and 
patient activation for MS patients (Demaille-Wlodyka, Donze, Giveron, & Gallien, 2011). Given 
the gap in the literature, in addition to the current impetus for patients to become more active and 
effective managers of their health care (Greene & Hibbard, 2012), it is hopeful that this quasi-
experimental study will address the literature gap and improve patient outcomes. Another 
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significant benefit of the project is the opportunity to evolve Advanced Practice Nursing (APN) 
translation of research into practice (Terry, 2012). 
Theoretical Foundation 
Encouraging self-efficacy among patients who have been diagnosed with MS can assist 
them in coping with the disease progression and symptom management, as well as additional life 
stressors that may occur that are not disease-related.  Self-efficacy has been identified in various 
research literature sources as being a significant predictor of positive engagement in health 
promoting behaviors among patients diagnosed with MS (Stuifbergen et al., 2000).  Self-efficacy 
is a social cognitive concept introduced by Albert Bandura (1993), consisting of four processes: 
cognitive, motivational, affective, and selection.  According to Bandura (1993), self-efficacy 
plays a major role in whether or not an individual achieves a successful outcome in his or her 
goals, tasks, and challenges throughout life.  Bandura (1994) described self-efficacy as the 
beliefs held by an individual in his or her ability to succeed in a given situation, with the beliefs 
being influenced by things such as how an individual thinks (cognitive), plans (motivation), feels 
(affective), and behaves (selection).  If an individual is presented with a situation in, which he or 
she feels confident in the ability to succeed, the likelihood of a positive outcome and 
achievement of a goal is increased (Bandura, 1994).  Likewise, if an individual is not confident 
in his or her abilities, the goal will, most likely, not be met.  Individuals who have a strong sense 
of self-efficacy are more likely to view challenges as tasks and opportunities to be mastered, 
develop a deep interest in the activities in which they take an active role, and recover more 
quickly from a setback.  In comparison, those with low senses of self-efficacy are reticent when 
facing challenges, focus on negative outcomes of previous attempts, and believe that tasks, 
which are difficult, lay outside the realm of their abilities.  
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 Self-efficacy is also thought to play a role in treatment adherence among patients who 
have been diagnosed with various diseases (Stuifbergen et al., 2012).  Additional research into 
the role self-efficacy plays in the management of MS symptoms suggests quality of life can be 
improved when physical activity is maintained, even when physical mobility is compromised 
secondary to the effects of the disease (Motl & Snook, 2008).  Activities such as aerobics and 
yoga have been shown to be beneficial in increasing the quality of life among individuals who 
are experiencing the physical and cognitive symptoms associated with MS (Motl & Snook, 
2008).  While self-efficacy may not be directly related to an improved quality of life, it appears 
to play a pivotal role in supporting health-related activities that can contribute to a better outlook, 
thus resulting in increased enjoyment and effective coping skills ultimately translating to 
improved quality of life. 
 In addition to Bandura’s theory, Margaret Newman’s theory of health as expanding 
consciousness provides a strong nursing foundation for the project.  Newman’s theory was 
designed for the patient for whom full health may never be a reality.  This theory is significantly 
applicable, as patients participating in the project will have a chronic progressive disease 
process.  Newman asserted each individual has a predestined path, and no matter how difficult, it 
is part of a greater plan.  This greater plan includes finding meaning in life, regardless of one’s 
circumstances as well as meaning and or connection with others in the universe (McEwen & 
Willis, 2011). 
Newman went on to elaborate that humans are constantly in contact with the 
environment, and therefore constantly changing in response to the environment.  Each person 
will develop an individual pattern of consciousness.  McEwen and Willis (2011) quoted Newman 
in their text, stating, “Persons as individuals, human beings as a species, are identified by their 
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patterns of consciousness… the person does not possess consciousness, – the person is 
consciousness” (p.184).  According to this assumption, a person’s illness would then be simply 
his or her unique pattern of consciousness.  In Newman’s theory, consciousness includes 
cognitive as well as affective awareness, and a connection with the environment, which includes 
maintenance of health and illness (Newman, 2013). 
Newman’s definition of health as expanding of consciousness, inclusive of illness, 
encompasses ongoing changes in harmony with the ever-evolving energy of the environment.  
Expanding consciousness includes the entire pattern of consciousness, and refers to the 
awareness and the development of self, in conjunction with the environment.  It is the process of 
assisting patients to realize and obtain their full potential (McEwen & Willis, 2011).  Newman 
postulated health and illness should be as one.  In fact, both states together should be viewed as 
the entity of health.  Health is determined to be a pattern; patterns are pieces of a whole and 
pattern recognition is essential to health awareness.  Pattern recognition involves being able to 
look past the pieces and parts of our lives in order to recognize patterns when combined, will 
produce expanded consciousness.  Pattern recognition will come from self-awareness, is unique 
to each individual, and will change over the course of time (McEwen & Willis, 2011).  The hope 
is for each patient to be able to look within himself or herself and find the inner strength to deal 
with a chronic progressive disease.  It is hopeful that this revelation will come about through 
increased knowledge of the disease process.  
Literature Selection and Scope of Evidence 
 Much of the research in the field of MS has focused on the disease, rather than on how to 
assist the patient to cope effectively with the diagnosis and the progressive nature of the disease.  
There appears to be a lack of studies that examine therapeutic patient education (Demaille-
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Wlodyka et al., 2011), which not only impacts the lives of those diagnosed with MS, but also the 
family, support system, and healthcare providers. 
 In order to assess the literature that has been published on the topic, various databases 
were utilized.  These consisted of the Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), Cochrane, Google Scholar, Medline, OVID, and PubMed.  The following search 
terms were used to find appropriate and applicable literature sources: care coordination, chronic 
disease, cost utilization, decision making, decision support system, disease management, 
evidence based medicine, health knowledge, health promotion, informed choice, MS, patient 
activation, patient autonomy, patient education, patient empowerment, self-care, self-efficacy, 
and self-management.  Utilizing these search parameters, 97 articles were located with 36 
articles evaluated according to the levels of evidence.  Eighteen met the criteria for Level I, 
seven for Level II, three for Level III, three for Level IV, four for Level V, and one for Level VII 
research (Houser & Oman, 2011). 
Review of Evidence 
Background of Problem 
 The National MS Society, certified MS nurses, as well as the National Institute of 
Neurological Disorders and Stroke have all agreed that the lack of disease education for newly 
diagnosed MS patients can lead to a less than optimal outcome in regards to both patient health 
prognosis and the monies spent annually on both direct and indirect costs associated with MS.  In 
2014, the National MS Society assembled a group of researchers, MS professionals, as well as 
patients who had been living with the symptoms of MS, to evaluate the current body of research 
regarding diet, exercise, and emotional wellness, aimed at identifying the gaps in knowledge on 
these topics, in order to develop educational resources and support programs for MS patients, 
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families, caregivers, and healthcare professionals who work with MS patients (National Multiple 
Sclerosis Society, n.d.). 
 Several gaps in knowledge were identified in regards to MS programs that are currently 
in place, which, if left unaddressed, could allow the cost of direct and indirect treatment care to 
continue to escalate.  The committee discovered that there was a lack of continuity in the 
determined efficacy and effectiveness of the numerous wellness programs that are currently in 
place, particularly in regards to symptom management, the reduction of comorbid health 
conditions, and methods used to enhance the impact the disease-modifying therapies currently 
use for the treatment of MS (NMSS, n.d.). 
 Three recommendations arose from the study conducted by the NMSS in 2014: 
 Engage research design experts to address the challenges identified within and 
across wellness areas. 
 Stimulate collaborative research efforts, similar to what has been done in the areas 
of genetics, nervous system repair, and progressive MS, to ensure that the best 
minds are working with speed and effectiveness in wellness research. 
 Identify funding partners who share the interest of increasing knowledge about 
wellness interventions in MS. 
Systematic Review of Literature 
 According to a review of the literature addressing educational interventions for patients 
with MS, it seems the current methods may be insufficient, as many of the therapeutic, 
educational programs lack both standardization and assessment of efficacy (Demaille-Wlodyka 
et al., 2011).  Despite these shortcomings, however, the numerous benefits of an educational 
intervention have been noted.  The use of educational therapy has been shown to reduce the 
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impact of the disease symptoms that are associated with MS, such as cognitive and self-care 
disturbances (Demaille-Wlodyka et al., 2011). Such educational programs are also thought to 
have a positive effect on self-care practices (Lillyman & Farquharson, 2013). Through teaching 
patients what to expect and the treatment options that are available, a sense of dignity and self-
efficacy can be maintained despite the challenges that may accompany the progressive nature of 
the disease. By educating patients and their families regarding the possible psychological, 
physical, emotional, and cognitive changes that can accompany MS, an accurate understanding 
of the disease can be gained. 
 Kopke, Richter, Kasper, Muhlhausr, Flachenecler and Heeson (2012) enlisted 261 MS 
patients to participate in a study related to relapse and relapse therapy, providing them with four 
hours of instruction in addition to a comprehensive brochure.  Perceptions of autonomy for 
treatment decision-making were considerably higher for patients receiving an educational 
intervention than a control group.  The study additionally confirmed MS patients were able to 
cope with information about uncertainties of the disease process as well as treatment options.  
Interestingly, the study documented frequent fears and objections by physicians providing patient 
instruction. 
In a level II, randomized controlled study, Adamczyk, Flis, Zyarycha and Rejszel (2002) 
evaluated the effectiveness of health education in patients with neurological issues of stroke and 
MS.  The study provided three weeks inpatient education and showed a 26 percent increase in 
knowledge following the first stage of the project and 64 percent increase after the second stage, 
concluding a “radical increase in the level of health-promoting knowledge among patients in a 
controlled environment” (p. 67). 
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In other countries, a program has been introduced which provides patients with a 
comprehensive education aimed at providing patients and their caregivers realistic expectations 
as MS progresses. The program, known as Therapeutic Patient Education (TPE) has been 
implemented in Europe and has been shown to be quite beneficial in reducing the number of 
hospital visits related to MS symptoms (Demaille-Wlodyka et al., 2011). Due to the varied 
nature of the numerous symptoms that are associated with the disease, development of 
specialized training programs addressing specific MS symptoms would be beneficial to patients. 
Additionally, education regarding treatment interventions should be adaptable in order to account 
for possible side effects of medications that are frequently used to treat some of the symptoms 
associated with MS, which, depending on drug class and dosing, can slow or hinder cognitive or 
physical abilities of an individual. 
 A review of self-management interventions revealed that the use of such programs 
targeted at improving the self-efficacy of individuals with MS has yielded promising results.  
When designing educational interventions for neurological disorders, it is important to tailor 
each program to the specific needs of both the individual disease as well as the patient who will 
be receiving the information (Rae-Grant et al., 2011). Programs addressing neurological 
disorders should bear in mind the unique challenges that are associated with a chronic disorder 
such as MS, which consists of period of remission and acute exacerbation and disease 
progression over time, to the point of physical and potentially mental incapacitation. Research 
into MS specific education interventions suggest positive outcomes are associated when the 
focus is on overall health behaviors and self-efficacy skills such as exercise programs, goal 
setting, and healthy coping strategies to effectively address the debilitating fatigue, stress, and 
pain that often accompanies the disease (Rae-Grant et al., 2011). At the current time, however, it 
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appears that a uniform program that delivers such options does not exist, at least not on a large 
scale or national level. 
 When studying educational interventions that have been shown to be beneficial for other 
neurological conditions, the inclusion of improving self-efficacy along with disease education 
has proven to be central to a successful outcome. Patients with MS report that self-care skills are 
among the most important in allowing them to maintain a sense of autonomy, thus potentially 
contributing to a better outlook and improved quality of life (O’Hara, de Souza, & Ide, 2000). 
Some aspects of self-care that have been reported as being essential include following a specific 
dietary regimen, healthy and positive stress coping skills, complementary therapy such as yoga, 
and activities that are associated with living independently (O’Hara et al., 2000). By including 
the aspects that patients have identified as being important, the proposed educational intervention 
can have a higher likelihood of addressing the needs of the patient, rather than basing the 
guidelines on textbook and diagnostic criteria. 
 Other educational programs aimed at patients with MS have shown great benefits when 
the information is presented in close proximity to receiving the diagnosis. Newly diagnosed 
patients may not be aware of the various symptoms that are associated with MS, or the 
progressive nature of the disease. One study evaluated the use of a specifically designed 
educational intervention for individuals who had recently received a diagnosis of MS, which 
consisted of an interview with a physician, an informative CD, and a take-home booklet, 
significantly increased the likelihood of a positive outcome, which was defined as a high level of 
attainment of disease knowledge with a high satisfaction with the care they had received (Solari 
et al., 2010). When the information is presented within two weeks of diagnosis, the retention of 
the information was greater, even when follow-up assessments were conducted at six months 
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after the initial educational intervention. While the information about the disease may be viewed 
as overwhelming for some patients, research suggests that anxiety was not markedly increased 
among patients who received the educational intervention used by Solari et al. (2010). The 
specific intervention has not been tested, however, on patients who have had a history of 
substance abuse, psychiatric conditions, or impaired cognitive ability. 
 Education on symptom management has been shown to be associated with a higher 
quality of life, as it can allow the patient to be better prepared for the potential effects of MS as 
well as providing an opportunity to learn about treatment options, thus leading to a more realistic 
understanding of the disease. Most educational interventions used for patients who have received 
a diagnosis of MS focus on two main aspects: disease modifying therapy choices and therapeutic 
options to address the symptoms of the disease (Ben-Zacharia, 2011). While focusing on the 
aspects of disease and symptom management have been shown to be beneficial, such an 
approach may not sufficiently increase the level of self-efficacy. 
 Measuring the quality of life can be difficult, as there are many facets which are deemed 
important, and the ranking of the variables can differ depending on both the individual and the 
disease. According to research regarding the quality of life, the severity of illness, antecedent 
variables, and health promoting behaviors have been identified as primary factors that contribute 
to either a higher or lower quality of life experienced by the individual (Stuifbergen, Seraphine, 
& Roberts, 2000). Designing an educational intervention for patients with MS can be extremely 
challenging due to the frequently unpredictable nature of the disease. Nevertheless, by focusing 
on increasing self-efficacy, which has been associated with a higher quality of life, the program 
can allow for the patient to navigate through the various symptoms which can include weakness, 
numbness, pain, bowel and bladder problems, and changes in sexual functioning (Stuifbergen et 
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al., 2000).  The diverse symptoms that accompany MS can make the development of a 
specifically tailored program focusing on nurturing self-efficacy rather than solely on the 
symptoms, a beneficial approach. 
With healthcare transitioning to a system that will expect the patient to effectively 
assume primary responsibility for managing chronic conditions, Battersby, Von Korff, Schaefer, 
Davis, Ludman, Greene, Parkerton and Wagner (2010) conducted a meta-analyses of 83 articles 
related to self-management.  The conclusion supported the positive role of education within a 
medical practice enabling patients to successfully care for their chronic conditions.  The authors 
recommended the use of a Care Manager responsible for patient education.  
Project Plan and Evaluation 
Strengths, Weaknesses, Opportunities, and Threats 
 Given that identifying strengths, weaknesses, opportunities, and threats (SWOT) assists 
in projecting a path for a project, an analysis was completed to determine the feasibility of an 
educational curriculum for MS patients.  A SWOT analysis is a framework for identifying and 
analyzing the internal and external factors that can have an impact on the viability of a project, 
product, place, or person.  The SWOT analysis was used to determine how internal strengths 
could be used to take advantage of opportunities and avoid threats, as well as how weaknesses 
could be overcome by taking advantages of opportunities. 
 Strengths of the project include strong support from key stakeholders, location of the 
project within a specialty MS practice, and the convenience sampling is accustomed to meeting 
regularly. Weaknesses of the project include time constraints, travel distance to the clinic, and 
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the utilization of a convenience sampling within one practice. The possibility of not reaching 
power is another real weakness.  
Opportunities of the project include increased self-care efforts of patients following an 
educational program and the potential for the curriculum to be used by other practices.  Threats 
to the project include the short duration of the education module, lack of continued 
reinforcement of new concepts, high potential for project dropout due to health or travel reasons, 
and the timing of the project.  
Table 1.  SWOT Analysis 
IN
T
E
R
N
A
L
 
STRENGTHS 
 
Strong support from key 
stakeholders 
Project located within MS specialty 
practice 
Participants accustomed to meeting 
regularly 
 
WEAKNESSES 
 
 Convenience sampling within one 
practice 
 
 Time constraints 
 
 Potential travel distance 
E
X
T
E
R
N
A
L
 
OPPORTUNITIES 
 
Increased patient education may result 
in better outcomes 
 
Potential for use by other practices 
 
THREATS 
 
Short duration of study 
 
High potential for dropout 
 
Project timing (weather impacting travel) 
 
While it is not possible to remove all threats to validity and reliability in most studies, 
certain precautions can be taken in order to reduce such risks.  For this capstone project, 
precautions were taken to ensure that the data gathered and analyzed was an accurate 
representation of the pre- and post-educational curriculum intervention scores. The DNP 
capstone lead administering and scoring the MSKQ received specialized training to ensure that 
the instructions were understood. The questionnaire used has been shown to be effective in 
   20 
 
 
 
measuring knowledge of MS and the associated symptoms when used in diverse populations, 
with varied educational levels (Giordano et al., 2010). Additionally, the same DNP capstone lead 
who administered the pre-educational curriculum intervention also administered the post-test 
questionnaire, thus reducing the instrumentation threats to internal validity. 
Driving and Restraining Forces 
 Another element similar to SWOT was the identification of driving, restraining, and 
sustaining forces.  According to Zaccagnini and White (2014), the capstone project should focus 
on an identified practice problem and the application of evidence to the problem, thus leading to 
change.  In order to accomplish change, Kurt Lewin’s Force Field Analysis was used as a 
strategic tool to understand how change should occur.  Driving forces for consistent 
implementation of a MS education program included the prevalence of MS, the mean lifetime 
cost per patient, and the possibility of decreased healthcare costs resulting from effective 
education.  Restraining forces consisted of delayed diagnosis, lack of adequate education on the 
part of primary care physicians and the lack of disease education programs offered.  The 
sustaining force will attempt to guarantee that adequate reinforcement of the change will be 
provided to ensure the desired change is accepted and maintained into the future.  Without this 
type of sustainability, patients tend to return to previous norms (Change Management Coach, 
n.d.). 
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Figure 2.  Force Field Analysis 
Feasibility, Risks, Unintended Consequences 
 The proposed MS education policy is legally, administratively, and politically feasible.  
This program can be easily initiated via the National MS Society’s Knowledge is Power series 
(NMSS, n.d.) at no additional cost to the society, hospital, or patient.  The program can be taught 
by current health system staff, which would not require additional personnel or salary for 
specialists or educators.  In addition, patients can be referred within the hospital network for the 
educational program, at no extra cost.   
Risk to participants was minimal.  In the event the measurement tool produced anxiety, 
debriefing, emotional support or counseling was available by a certified MS nurse.  There were 
no unintended consequences.  
Stakeholders and Project Team 
 Zaccagnini and White (2014) define stakeholders as key individuals who will be affected 
by a project.  In the capstone project, stakeholders are identified as the various entities that will 
have a stake in the development and effectiveness of a MS educational program.  The capstone 
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project team included Tamara Miller, M.D., medical director of Advanced Neurology, Dr. 
Miller’s clinical studies nurse, Lillie Denny, RN, Colleen McCallum, DNP, RN, FNP-C, 
Capstone Chair, and Anna Parton, MSN, RN FNP-C, the DNP capstone project lead.  Expected 
stakeholders include patients, families, primary care providers, neurologists, health networks, 
and the insurers, both public and private.  Patients, families, and caregivers will benefit from the 
outcome of introducing the MS educational program by gaining an increased knowledge about 
the projected course of the disease, as well as benefitting from the increased self-efficacy and 
improved quality of life that have been shown to accompany the use of various educational 
interventions. 
 Primary care providers and neurologists can benefit from the development of an MS 
educational program given they will be dealing with a more educated patient, as well as possibly 
reducing the workload by more effective patient self-care.  Given the reduced reliance upon 
primary care and specialists observed when such programs are employed, insurance companies, 
as well as the healthcare system in which the programs are utilized, should find the program 
financially feasible. 
Cost-Benefit Analysis 
Since it has been estimated that the cost of care for MS patients in the United States is 
near $30 billion annually (NMSS, n.d.), the lack of effective educational interventions ultimately 
cost hospitals and insurance companies.  These costs are in terms of not only finances, but also 
diverted resources, including healthcare providers, from tending to other health issues.  In other 
terms, the knowledge deficit costs valuable time and money, for the patients, healthcare 
providers, and the insurance companies. 
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The cost of treating the symptoms associated with MS has been estimated at $39,000 
annually in just healthcare costs, with a total of $69,000 for both the direct and indirect costs 
(NMSS, n.d.). While the costs are quite high, studies suggest that the cost of not treating the 
symptoms of MS may be higher (Rocky Mountain Multiple Sclerosis Center, 2015).  The use of 
targeted educational programs can aid in reducing the costs associated with care and treatment 
for individuals with MS.  The projected health care cost savings associated with the introduction 
of an education program should prove to be quite lucrative for the patients, healthcare providers, 
hospitals, insurance companies, and other stakeholders.  For example, the baseline costs for 
health care for MS patients who do not receive the training are estimated to be $39,000.  After 
the first year of introducing the educational program (which will be offered free of charge to the 
patient), the cost savings are $3,042 per year; after five years, the projected cost savings are 
estimated at $13,015, the cost of one exacerbation (RMMSC, 2015), reducing the healthcare cost 
from $39,000 to $25,985 per year.  If every MS patient in the United States were to receive an 
educational training program, increasing patient activation and efficacy, the estimated savings 
could be $5,206,000,000 after five years, which is quite sizable. 
 On a global scale, the prevalence of MS is not exactly known, as there is currently no 
mandatory registry for MS. It is estimated, however, that approximately 2.5 million individuals 
live with the symptoms of MS.  Outside of the United States, which has an estimated 400,000 
cases total, or 200 new cases each week, equating to a prevalence of 140 cases per 100,000 
(NMSS, n.d.).  Other countries are experiencing similarly high rates; the United Kingdom, 
Norway, Sweden, Germany, the Czech Republic, Hungary, and Cyprus all have rates that fall 
between 149 and 189 per 100,000, but Canada and San Marino have a prevalence of 291 and 250 
per 100,000 respectively (Pietrangelo & Higuera, 2015). 
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 The countries that have the highest prevalence of MS obviously experience the greatest 
total costs, per patient, on an annual basis.  According to a review of the medical costs, Sweden, 
which has one of the highest rates of MS (189 per 100,000), also has one of the highest 
documented total medical costs per patient, estimated to be $54,465 annually, while the weighted 
average of MS care is $41,335 per year (Trisolini, Honeycutt, Wiener, & Lesesne, 2010).  It is 
probable, due to the age of the review from which the figures were obtained, that the current cost 
is much higher.  Additionally, these estimates of care for MS patients only factor in the direct 
and indirect medical costs, such as loss of income due to early retirement, informal care, 
professional home care, hospitalizations, prescriptions, and disease-modifying drugs.  The true 
cost is much higher, as the direct and indirect costs do not include intangible costs, such as the 
quality of life, utility measures, and the impact on family and friends (Trisolini et al., 2010).  
More severe, debilitating cases of MS take an enormous toll on the healthcare system as well as 
an association with severely reduced quality of life for not only the patient, but also the family 
and other care or support systems. 
 It has been speculated that over 400,000 people are currently living with the symptoms of 
MS in the United States, with the actual number estimated to be much higher due to the invisible 
symptoms that often accompany the disease, as well as the lack of a national registry (NMSS, 
n.d.).  The cost of medications alone for the management of symptoms is estimated to be 
between $20,000 and $30,000 annually, with the cost for treating an exacerbation at just under 
$13,000 per episode (RMMSC, 2015); however, since MS typically occurs during what is 
considered to be the most productive years (between 16 and 45 years of age), the cost is much 
higher when the loss of future wages due to inability to work outside of the house is factored in, 
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which increases the annual cost for the treatment of the disease in the United States to over 
$50,000, or $2.2 million to cover the lifetime costs associated with MS (RMMSC, 2015). 
 A study of the personal and social impact MS has on the patients in Europe revealed that 
the burden, both financially and in terms of the quality of life experienced are quite high. It is 
thought that the burden increases as the disease progresses, as the majority (80%) of individuals 
who  have received a diagnosis experience impaired mobility within 10-15 years (Pike, Jones, 
Rajagopalan, Piercy, & Anderson, 2012), which is frequently associated with low employment 
rates (Jennum, Wanscher, Frederiksen, & Kjellberg, 2012).  The low employment rates place a 
higher toll on the caregivers and MS patient, leading to significant socioeconomic impact. 
 Reduced mobility, often associated with MS, has been found to be strongly related to a 
decreased quality of life in regards to health-related disorders, not only for the patient, but in 
terms of the financial, emotional, and physical burden placed on the caregivers, both formal and 
informal (Pike et al., 2012).  Such burdens can be considerable, with caregivers experiencing a 
decreased quality of life as well.  Reduced mobility has also been shown to have an influence on 
the development of psychosocial issues, such as the development of clinical depression and 
anxiety, sexual dysfunction, changes in cognitive ability, and an increase in the amount of 
demoralization and grief experienced by MS patients (Kirzinger, Jones, Siegwald, & Crush, 
2013).  The combination of psychosocial and socioeconomic impact that has been observed to 
occur in patients with MS and their caretakers can have a severe effect on the quality of life. 
 The amount of health care resource utilization also increases when an individual with MS 
experiences mobility problems, with increases most often witnessed in primary care visits, 
urology consultations, therapy appointments, and the use of expensive long-term drug use 
outside of disease modifying therapies (Pike et al., 2012).  The utilization of these services, 
   26 
 
 
 
however, has been observed to decrease when educational programs and interventions 
specifically aimed at improving the ability of the individual to increase his or her mobility, 
leading to a positive socioeconomic impact (Pike et al., 2012). 
 While some individuals with MS may experience fewer symptoms and not become 
debilitated by the disease, others are not as fortunate.  Early detection of potential symptoms of 
MS can help to prompt the use of the educational program, which, according to various studies 
can help to improve the outcome, while reducing the number of visits to physicians and hospitals 
for MS-related symptoms (Demaille-Wlodyka et al., 2011).  It is hoped that the introduction of 
an MS educational program will: 
 Reduce the number of hospital visits/admissions 
 Decrease the overall cost associated with treating MS 
 Increase the self-efficacy of patients 
 Reduce the disease burden on the family and caregivers 
 Increase the quality of life experienced by the patients, family, caregivers, and support 
system 
 Increase adherence to treatment protocols 
 Increase symptom management by patients 
Considering the enormous cost of MS to the healthcare system, patient education is a 
relatively inexpensive solution to decrease total as well as individual cost of the disease process.  
Costs included approximately 80 hours of advance practice nurse (APN) labor, printing, and 
universal serial bus (USB) thumb drives for patients.   
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Table 2:  Actual cost of project 
Conference room and audiovisual equipment Provided by practice 
APN labor for prep (design of education 
modules, teaching, data collection and analysis 
80 hours @ $50/hr = 
$4000 
Printing  $35 
USB drives 20 @ $9/each = $180 
Gift cards for participants 20 @ $15/each = $300 
Total $4515 
 
Mission, Vision, Goals 
 The mission of the MS education project focused on providing education to newly 
diagnosed MS patients, families, and caregivers with the ultimate goal of determining the impact 
of education on patient activation and self-efficacy.  By expanding the information to others 
outside of patients, families and caregivers can learn what to expect as well as understand how to 
identify symptom progression.  Additionally, the education presented can help to enhance 
knowledge and facilitate self-management through having a better understanding of the disease 
process (Lillyman & Farquharson, 2013).  Other goals of the MS educational project include: 
● Realistic expectations, which will result in less fear 
● Improved self-care and symptom management 
● Decreased quantity and severity of exacerbations 
● Decreased hospitalizations due to MS symptoms 
● Increased quality of life for both the patients and their caregivers 
 The MS education program fits well with the established vision and goal of the MS 
Society.  Through providing a structured MS education training session to each newly diagnosed 
MS patient and their families, offering it as a standard practice measure can enhance knowledge 
and facilitate a better understanding of the disease process (Lillyman & Farquharson, 2013). 
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Figure 3.  Mission, Vision, Goals 
Primary Outcome Objectives and Measures 
 In this capstone project, the primary outcome measure is the ability of the patients to 
assume increased responsibility of their disease process and become more independent in their 
care as a result of increased knowledge. Terry (2012, p. 1) states, “In the broadest sense, 
outcomes in health care are the result of interventions based on the use of clinical judgment, 
scientific knowledge, skills, and experience.” Increased knowledge will be determined by the 
pre- and post-educational intervention levels attained by the patients during the intervention.  
Subjective evaluation of independent symptom(s) management and appropriate utilization of 
health care resources could be considered as well.  These markers were selected as primary 
outcome measures for the potential contribution to future patients and healthcare professionals 
who work with MS patients. 
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Logic Model 
 The proposed conceptual model of MS education, as seen in Table 2, addresses the 
community assets that will be needed to implement a structured curriculum as well as the 
strategies to reach the goal and the assumptions behind both the how and why the educational 
program will work in the community.  The intended location of the educational program is a 
neurological office in the southern United States.  The goal of the proposed program is to create 
a uniform program that can provide patients with enhanced knowledge of MS and increased 
confidence related to self-care activities.  In order to measure the usefulness of the program, the 
Multiple Sclerosis Knowledge Questionnaire (MSKQ) will be implemented to test the 
knowledge prior to the educational intervention, and then upon completion of the program (See 
Appendix A for logic model). 
 
Table 3: Conceptual Model of Multiple Sclerosis Education 
Problem or Issue Patients who have been diagnosed with MS can often feel defeated after 
receiving their diagnosis. In some instances, doctors and other healthcare 
professionals may inform the patient of the diagnosis without providing 
education. In turn, the patient may experience stress associated with the 
diagnosis. 
Community 
Needs/Assets 
A formal, structured, reproducible educational curriculum which will 
include pathophysiology, symptom expectations, treatment options, and 
prognosis is needed for newly diagnosed MS patients.. The program will 
require the participation from patients, providers, and technical assistance 
for program implementation. 
Desired Results 
(outputs, 
outcomes, and 
impact) 
An increase in knowledge resulting in a decrease of unrealistic 
expectations of patients related to their disease. 
 
An increase in patient education leading to an increase in patient 
enrollment in treatment options. 
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More effective symptom management. 
 
Comprehensive program that can provide education to both healthcare 
professionals and patients. 
 
A more informed community. 
 
A healthier patient population with greater quality of life. 
Influential Factors Time available to develop the program. 
 
Money to fund the research and implementation of the program. 
 
The facilities available to hold the training for the clinicians and 
healthcare professionals, as well as the patients who have been diagnosed 
with MS. 
 
Strategies Through the creation and distribution of promotional materials and 
educational curricula, more patients can benefit from a specialized 
program that can be designed for use nationwide. 
 
Providing health screenings and training for hospital settings which can 
help to identify patients that would benefit from the intended intervention 
and educational program. 
 
Include patients and providers in the decision making process for program 
implementation. 
Assumptions The more information a patient has, the better informed he or she will be 
about the reality of the disease progression, as well as the treatment 
options that are available. 
 
Education about health issues can increase the quality of life for people 
who are affected by MS. 
 
Communities can influence public policy if they are informed of the 
potential benefits the intended changes can contribute to public health. 
 
Information fuels decision making ability. 
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Population and Sampling 
Sample sizes are critical to the overall outcome of a study, as a small sample size may not 
have enough power to detect a change, resulting in a type II error (Polit, 2010) and may not 
capture an accurate representation of the larger population.  When working with a homogenous 
population, as in the case of patients who have been diagnosed with MS, purposive sampling was 
deemed an appropriate method (Terry, 2012).  Due to the confines of the parameters (patients 
diagnosed with MS in one clinic in the United States), the sample was relatively small, but still 
representative of the target demographic. 
To secure the convenience sample, flyers announcing the program were placed in 
strategic locations where MS patients frequent such as the physician’s clinic, a neurological 
rehabilitation unit, and two MS Society branch offices.  Enrollment was open to MS patient age 
18 and older who could read and write English and their caregivers as well as interested staff 
persons.  Non-English speaking patients and patients under the age of 16 were excluded.  
Participation could cease at any time, as participation was voluntary.   
A power analysis with an alpha of 0.05 suggested a sample size of 50 participants for a 
medium power of 80 percent (Polit, 2010).  The relatively small sample size of 11 used in the 
study proved to be a challenge when attempting a power analysis.  When using a larger sample 
size, the power is also larger.  The larger the power, the more likely the results will be accurate 
(Polit, 2010).  In order to assess the effect size, it will be necessary to calculate the mean of the 
pre-intervention minus the mean of the post-intervention, divided by the common error variance, 
resulting in a d value; a d value of 0.2 would suggest a small effect size and a d value of 0.8 
would indicate a large effect size (Polit, 2010).  Using a paired t-test has much more statistical 
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power when the difference between the groups is small relative to the variation within groups 
(McDonald, 2014).  
Protection of Human Rights 
The proposed research will involve the use of educational tests (cognitive, diagnostic, 
aptitude, achievement), survey procedures, interview procedures, or observation of public 
behavior.  This information, along with the fact that the study will not involve members of 
vulnerable populations, meets exempt status as defined by the Department of Health and Human 
Services Code of Federal Regulations (DHS, 2009), and will allow for an exempt status request 
of the Regis University IRB (See Appendix B for IRB approval).  The identified MS specialty 
practice does not possess an IRB, therefore outside approval will not be required (See Appendix 
C for letter of support).  Participation will be voluntary, and patients may withdraw from the 
study at any time, without penalty or loss of benefits, and their responses will remain 
confidential. 
The study posed minimal risk to participants, there was, however, a possibility of the 
measurement tools causing anxiety for patients.  Debriefing, emotional support, or counseling 
services were available by a certified MS nurse and qualified mental health provider if needed.  
Information obtained was not be recorded in such a manner that patients can be identified, 
directly or through identifiers linked to the patients; and no disclosure of the human participants’ 
responses outside the research could reasonably place the patients at risk for criminal or civil 
liability or be damaging to the patient's’ financial standing, employability, or reputation, keeping 
in line with the code set forth by the U.S. Department of Health and Human Services (2009). 
Anonymity and confidentiality was protected by the use of numbers rather than names, 
and data was aggregated to further protect confidentiality.  Furthermore, the information will be 
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kept confidential, as the investigator will be the sole user of the data, which will be stored on a 
password-encrypted computer.  According to the guidelines, the de-identified data will be kept in 
locked storage for three years.  In addition, the primary investigator completed the Collaborative 
Institutional Training Initiative (CITI) as part of the human research curriculum as requested by 
faculty.  (See Appendix D for CITI certificate).   
Reliability/Validity of Instruments 
 This study utilized a single group, quasi-experimental design with a pre-test and post-test 
approach.  The sample population was chosen through convenience sampling of patients with a 
confirmed diagnosis of MS.  The difference in the amount of knowledge and self-efficacy gained 
due to the educational intervention was measured using the Multiple Sclerosis Knowledge 
Questionnaire (MSKQ) (See Appendix E for permission for use and instrument).  The MSKQ is 
highly reliable with a reported Cronbach’s alpha of 0.76 reliability (Ghojazadeh, Taghizadeh, 
Abdi, Azami-Andalib, & Farhoundi, 2014) by means of the Kuder-Richardson method.  
Additionally, the MSQK was developed with the concept in mind that a structured and targeted 
educational intervention is one of the main predictors in regards to knowledge about MS 
symptomatology, treatment options, and prognosis (Giordano et al., 2010), which made the 
MSKQ ideal for the current study. 
 The Patient Activation Measure (PAM) scale was administered in conjunction with the 
MSKQ to ascertain the level of knowledge, skills, and confidence the patients had managing 
their own health and healthcare (See Appendix F for permission for use and instrument).  The 
PAM is a valid, highly reliable, unidimensional, probabilistic Guttman-like scale that reflects a 
developmental model of activation.  The Rausch method of reliability for the 13-item PAM was 
0.85 and Cronbach's alpha was 0.87 (Hibbard, Stockard, Mahoney, & Tusler, 2004).   
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Treatment Procedure and Data Collection 
 The treatment/intervention education project consisted of four, two-hour sessions held 
every other week at a multiple sclerosis specialty center in a southwestern state.  Informed 
consent was not required per the Department of Health and Human Services Code of Federal 
Regulations (DHS, 2009); however, an information sheet was provided at the first education 
session.  The information sheet included contact information for the investigator, capstone chair 
and Regis IRB (See Appendix G for information sheet). 
The PAM and MSKQ pre-tests were completed during the first session.  Each sessions 
included a 35-slide power point presentation with numerous pictures, diagrams, and information 
appropriate for the identified topics including references.  Topics included anatomy and 
pathophysiology, diagnosis and treatment options, MS clinical features and symptom 
management, alternative therapies, the Affordable Care Act and self-efficacy and cost 
containment (see Appendix H for module outline).   
A PAM and MSKQ post-test were completed following the conclusion of the fourth 
session.  All participants were provided with a thumb drive containing all module content, six 
volumes of the National Multiple Sclerosis program Knowledge is Power, other public 
information from the National MS Society as well as additional MS patient education and 
reference materials collected by the investigator during the past two years of private practice.  
There were 58 documents included on the drive.   
Project Findings and Results 
 In order to assess the effectiveness of the educational intervention utilized in this 
Capstone project, a quantitative approach was used.  Through comparing the pre- and post-
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intervention scores that were achieved on the Multiple Sclerosis Knowledge Questionnaire 
(MSKQ) and the Patient Activation Measure (PAM), the effect of the educational intervention 
was identified.  Because the same participants completed the PAM and MSKQ before the 
educational intervention as well as after completion, a paired samples t-test was used to analyze 
the statistical significance of the data (Polit, 2010). 
 Statistical Package for the Social Sciences (SPSS), version 23 was used to examine the 
data that was gathered from both the MSKQ and PAM patient scores, with the raw data recorded 
on a Microsoft Excel spreadsheet.  A spreadsheet was selected due to the small sample size and 
the ability to observe the difference in MSKQ and PAM scored easily.  The data sets for the 
MSKQ and PAM scores, both before and after the educational intervention were normal, with 
skewness and kurtosis within acceptable ranges, which supported the use of the paired samples t-
test statistical analysis.  Kolmogorov-Smirnov and Shapiro-Wilk tests confirmed normality. 
Results 
 Due to participant dropout, there were only 10 individuals who completed both pre- and 
post-test conditions of the PAM assessment; the scores obtained from participants two, five, and 
ten were excluded from analysis due to the individuals being unable to complete one of the pre- 
or post-test conditions.  Eleven individuals completed both pre- and post-test conditions of the 
MSKQ assessment, with all 11 scores factored into the final statistical analysis of the MSKQ. 
 Scores for the pre-test condition of the PAM ranged from 45 to 91 (out of a possible 100), 
with a mean of 64 and a standard deviation of 13 for the 10 participants who completed both the 
pre- and post-test conditions.  The difference between the two conditions was found to not be 
statistically significant (p = 0.22) and the result size is not significant at p < 0.05. For the post-
test condition of the PAM, the scores ranged from 47 to 100, with a mean of 72 and a standard 
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deviation of 17. The scores on the MSKQ during the pre-test condition ranged from 44 to 100 
(out of a possible 100), with a mean of 75 and a standard deviation of 16. The difference between 
the two conditions was found to be statistically significant (p = 0.002), making the result 
significant at p < 0.05. 
Table 4 
Pre and Post means ± SD for the PAM outcome measures with an estimate of effect size using 
Cohen’s D 
 Pre ± SD Post ± SD p Cohen’s D 
PAM 64.0 ± 13.0 71.8 ± 17.4 0.22 0.49 
MSKQ 74.55 ± 16.42 92.36 ± 8.29 0.01 1.37 
 
Table 5 
Pre and Post means ± SD for the MSKQ outcome measures with ITT analysis with an estimate of 
effect size using Cohen’s D 
 Pre ± SD Post ± SD p Cohen’s D 
PAM 64.4 ± 13.2  71.9 ± 16.41 0.11 -0.50 
MSKQ 74.15 ± 17.09 89.23 ± 13.50 0.01 -0.98 
  
Based on the data obtained, the effect size between the pre- and post-test conditions in 
regards to the PAM, the Cohen’s d was 0.49, which is considered to be a medium effect size 
(Polit, 2010).  The difference between the pre- and post-test conditions in regards to the MSKQ 
scores provided a Cohen’s d of 1.37, which is considered to be a relatively large effect size.  
Such a result would suggest that the educational intervention program used in the current study 
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was effective in expanding the knowledge base of the participants in regards to MS.  Since the 
MSKQ has been observed to be both a reliable and a valid method of measuring MS knowledge, 
it can be ascertained that the results obtained in the current study regarding the MSKQ are also 
valid (Giordano et al., 2010). 
 Because intention-to-treat (ITT) is a cornerstone principle in the interpretation of 
randomized clinical trials (Detry & Lewis, 2014), the data was analyzed using this statistical test 
in addition to regular analysis. ITT includes every subject and ignores noncompliance, protocol 
deviations, withdrawal, and anything that happens after randomization. ITT avoids 
overoptimistic estimates of the efficacy of an intervention resulting from the removal of non-
compliers by accepting that noncompliance and protocol deviations are likely to occur in actual 
clinical practice. The ITT outcomes provided similar data to regular analysis (See Table 4). 
Discussion 
 The results from the current study suggest the educational intervention was effective at 
increasing the amount of knowledge for participants with respect to their disease and symptoms. 
Previous research has supported the claim that an educational intervention can help to increase 
the self-management practices as well as the health of those who complete such programs (Lorig 
et al., 2001). The results from the current study help to support this claim, as the scores on the 
MSKQ in the current study showed a statistically significant difference between the pre- and 
post-test points, with the majority of the participants experiencing an increase from their pre-test 
condition scores. 
 The hypotheses for the current study were supported by the results presented, as there 
was a difference between the mean values in the pre- and post-test conditions, following the 
introduction of the educational intervention. The use of targeted and structured educational 
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interventions for providing disease education to patients diagnosed with MS has been shown to 
be effective in providing a realistic picture of a progressive disorder such as MS (Giordano et al., 
2010). Again, the results of the current study supported the previous research claims on the topic 
of educational interventions, specifically in regards to MS. 
Limitations and Recommendations 
 Although the sample size was small and homogenous in regards to ethnicity (all 
participants were Caucasian), each participant served as his or her own control (pre-test 
condition), thus reducing the potential threat to internal validity. While the lack of diversity in 
the current study did not appear to have an influence on the effectiveness of the educational 
intervention, future studies could benefit from including individuals from a variety of cultural 
backgrounds, as some studies suggest that there may be a difference due to skin tones in regards 
to the development of MS (Langer-Gould, Brara, Beaber, & Zhang, 2013). If a difference exists, 
this difference could help to shape the course materials used in educational interventions for a 
more tailored experience. 
 Going forward, a longitudinal study with a larger sample size consisting of a diverse 
patient population would be recommended. Including a variety of ages and ethnicities could lead 
to a greater understanding of the effect of an educational intervention across a diverse 
population. While there are a variety of educational programs in place across the country for MS 
patients and their caretakers, development of a universal program providing the most current 
information and advances in research would be suggested. Such programs should incorporate a 
variety of topics, including the importance of exercise, the role stress management plays in 
effective symptom management, in addition to disease education and treatment options. 
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 While the idea of mandatory education may seem improbable, other countries have 
surpassed the United States in regards to the educational programs that are devoted to MS 
patients and their caregivers, often with much higher rates of MS than currently found in the 
United States. Through the implementation of a mandatory disease education program for newly 
diagnosed MS patients, the quality of life for MS patients and their caregivers can be improved, 
in addition to reducing the burdensome cost associated with care. The development of a national 
as well as a global registry for MS can also help to gain a better grasp of the severity of MS on a 
national and global scale, which can assist further research endeavors.  
 Conclusion  
 Currently, there is no requirement for patient education for newly diagnosed MS patients.  
As our health system is not nationalized, there is no way to mandate such a requirement; 
however, the literature and the results of this capstone project clearly show the benefit of patient 
education.  Newly diagnosed MS patients lack an adequate understanding of their disease 
process, leading to fear, anxiety, and poor coping skills, which often cause poor self-care, 
resulting in a diminished quality of life.  With utilization of an effective educational program, 
costs associated with treating MS may decrease, while allowing patients to enjoy a greater sense 
of autonomy and self-efficacy.  
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February 3, 2015 
Anna Parton 
8116 Golden Eagle Road 
Ft. Collins, CO 80528 
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Deru· Ms. Parton: 
Academic Grants 
IRB - REGIS UNIVERSITY 
3333 Regis Boulevard, H·4 
Denver, CO 80221·1099 
303·458·4206 
303-964·5528 fax 
www.regis.edu 
Your application to the Regis Hill for your project, "A Multiple Sclerosis Education Module to 
Promote Patient Activation and Efficacy", was approved as ail exempt study on February 2, 
2015. This study was approved per exempt study category of research 45CFR46.10l.b(#2). 
The designation of"exempt" means no further IRB review of this project, as it is currently 
designed, is needed. 
lf chru1ges are made in the research plan that significantly alter the involvement ofhurnru1 
subjects from that which was approved in tile named application, the new research plan must be 
resubmitted to tile Regis IRB for approval. 
Sincerely, 
@Gt.tt~~ 
J>atsy McGuire Cullen, PhD, PNP-BC 
Chair, Institutional Review Board 
Professor & Director 
Doctor ofNursing Practice & Nurse Practitioner Progrruns 
Loretto Heights School ofNursing 
Regis University 
cc: Patsy Cullen, PhD 
A JESUIT UNIVERSITY 
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ADVANCED 
NEUROLOGY 
OF COLORADO, 
LLC 
Diplomate American Board 
of Psychiatry and Neurology 
21ll East Harmony 
Suite 180 
Fort Collins, Colorado 80528 
PHONE: (970 )226-61 11 
FAX: (970) 226-6707 
TAMARA A. MILLER, M.D. 
PATRICIA FODOR, M.D. 
JILL OLSON, M.D. 
LILLIE L. DENNY R.N. 
TARA BERNHARDT R.N. 
October 30, 2014 
Regis University Institutional Review Board 
Denver, Colorado 
To Whom it may concern: 
Anna Parton is a Regis University Doctoral candidate who will be 
conducting research and education at Advanced Neurology of Colorado in Fort 
Collins, Colorado for our patients with Multiple Sclerosis who currently 
participate in a support group. We do not have an Institutional Review Board. 
This letter serves as approval for Anna Parton to conduct training and 
Research with the staff employed at Advanced Neurology of Colorado. 
Sincerely,~ c--~ 
D Tamara A. Miller, MD 
Medical Director 
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Appendix E 
 
Solari 
Alessandra <Alessandra.Solari@istituto-
besta.it> 
 
Nov 17 (13 days ago) 
 
 
 
to me 
 
 
Dear Ms. Panton: 
Enclosed you find the MSKQ and correct answers. Please note that this is an UK English translation (not a 
linguistic validation), the item on MS prevalence should be adapted. You should cite the MSKQ 
publication in any research product,  as follows: Giordano A, Uccelli MM, Pucci E, Martinelli V, Borreani 
C, Lugaresi A, Trojano M, Granella F, Confalonieri P, Radice D, Solari A; SIMS-Trial group. The Multiple 
Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. 
Mult Scler. 2010; 16(1):100-111. 
  
Sincerely, 
AS 
  
  
Dr. Alessandra Solari I MD Neurologist 
Acting Head, Unit of Neuroepidemiology 
Fondazione IRCCS Istituto Neurologico C. Besta 
Via Celoria 11 I 20133 Milan Italy 
tel: +39 02 2394 2391 I fax: +39 02 7060 6233 
Skype: Alessandra.Solari1 I e-mail: Alessandra.Solari@istituto-besta.it 
Before printing, think about environmental responsibility 
  
  
Da: Anna Parton [mailto:apartonnp@gmail.com]  
Inviato: lunedì 17 novembre 2014 03:36 
A: Solari Alessandra 
Oggetto: MSKQ 
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MULTIPLE SCLEROSIS KNOWLEDGE QUESTIONNAIRE 
 
This questionnaire assesses your knowledge of multiple sclerosis. Please read each 
statement and tick the letter that corresponds to the answer you consider correct. 
Please answer all statements, and tick only one answer for each statement. 
 
1. Multiple sclerosis is a disease of: 
a) The central nervous system 
b) All body organs 
c) Don’t know 
 
2. The central nervous system consists of: 
a) Brain 
b) Brain and spinal cord 
c) Brain, spinal cord and optic nerves 
d) Brain and peripheral nerves 
e) Don’t know 
 
3. In the United States, multiple sclerosis affects: 
a) About 5,000 people 
b) About 50,000 people  
c) About 575,000 people  
d) Don’t know 
 
4. Multiple sclerosis significantly shortens lifespan: 
a) True 
b) False 
c) Don’t know 
 
5. Multiple sclerosis is a disease of the immune system: 
a) True 
b) False 
c) Don’t know  
 
6. Multiple sclerosis is a contagious disease: 
a) True 
b) False 
c) Don’t know 
 
7. The causes of multiple sclerosis are still not completely clear. The 
    most important causes seem to be: 
a) Environmental (diet and smoking) 
b) Environmental (alcohol consumption and infections) 
c) Environmental (infection and smoking) and genetic (a number of genes) 
d) Don’t know 
   52 
 
 
 
8. Multiple sclerosis is a monogenic genetic disease. It occurs as a 
    direct consequence of a single defective gene which a parent with 
    multiple sclerosis passes on to his/her children: 
a) True 
b) False 
c) Don’t know 
 
9. The likelihood of a relative of a patient with multiple sclerosis having 
    the disease is: 
a) The same as a person with no MS in the family 
b) Slightly higher (less than 5%) than a person with no MS in the family 
c) Much higher (greater than 30%) than a person with no MS in the family 
d) Don’t know 
 
10. Multiple sclerosis injures: 
a) The myelin 
b) The axon (nerve fiber) 
c) Both myelin and axon 
d) Don’t know 
 
11. Multiple sclerosis can manifest at any age, but typically occurs: 
a) Before 20 years 
b) Between 20–40 years 
c) Between 40–60 years 
d) Don’t know 
 
12. Multiple sclerosis occurs in: 
a) Women and men about equally 
b) Men more than twice as often as women 
c) Women more than twice as often as men 
d) Don’t know 
 
13. Like the insulation of an electric wire, myelin facilitates and speeds 
      up the transmission of nervous impulses: 
a) True 
b) False 
c) Don’t know 
 
14. At present there is no single test/examination that can diagnose 
      multiple sclerosis with certainty: 
a) True 
b) False 
c) Don’t know 
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15. Magnetic resonance imaging (MRI) is the examination most 
      commonly used to confirm the multiple sclerosis diagnosis: 
a) True 
b) False 
c) Don’t know 
 
16. Intra-venous injection of contrast (gadolinium) during MRI reveals 
      lesions that are: 
a) Old 
b) Recent 
c) Both old and recent 
d) Don’t know 
 
17. MRI is repeated at intervals to better follow disease course over time: 
a) True 
b) False 
c) Don’t know 
 
18. Lumbar puncture is performed to assess the cerebrospinal fluid for 
      antibodies (oligoclonal bands) that indicate an immune reaction typical 
      of multiple sclerosis: 
a) True 
b) False 
c) Don’t know 
 
19. Lumbar puncture is repeated at intervals to better follow disease 
      course over time: 
a) True 
b) False 
c) Don’t know 
 
20. A definite diagnosis of multiple sclerosis: 
a) Can require repetition of MRI 
b) Is always possible at first disease attack 
c) Don’t know 
 
21. ‘‘Relapsing–remitting’’ multiple sclerosis is characterized by: 
a) Slow and progressive deterioration in functioning (increase in disability) 
followed, after months or years, by attacks (relapses) 
b) Repeated attacks (relapses) at more or less frequent intervals 
c) Don’t know 
 
22. A person diagnosed with “clinically isolated syndrome”, or “CIS”: 
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a) Has a disease which has nothing to do with multiple sclerosis 
b) In the event of a second attack (relapse) has confirmed multiple sclerosis 
c) Has multiple sclerosis (“CIS” is a synonym for multiple sclerosis) 
d) Don’t know 
 
23. Pregnancy worsens multiple sclerosis: 
a) True 
b) False 
c) Don’t know 
 
24. At present there is no treatment that can cure multiple sclerosis: 
a) True 
b) False 
c) Don’t know 
 
25. Disease modifying drugs are effective in: 
a) ‘‘Relapsing–remitting’’ multiple sclerosis 
b) ‘‘Primary progressive’’ multiple sclerosis 
c) Both ‘‘relapsing–remitting’’ and ‘‘primary progressive’’ multiple sclerosis 
d) Don’t know 
 
 
 
 
Giordano, A., Messmer Uccelli, M., Pucci, E., Martinelli, V., Borreani, C., Lugaresi, A., 
Trojano, M., Granella, F., Confalonieri, P., Radice, D. & Solari, A. (2010). The multiple 
sclerosis knowledge questionnaire: a self-administered instrument for recently diagnosed 
patients. Multiple Sclerosis, 16(1), 100-111. 
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Appendix F 
 
Craig 
Swanson <cswanson@insigniahealth.com> 
 
Nov 2 
 
 
 to me 
 
 
Anna: 
  
Thank you for the information you provided below as well as your interest in and online order of 
PAM.  Per the terms of your online order for your studies (PhD license category, sharing your 
data), I have attached the documents you need for your work: 
  
•             PAM survey and coaching guidance 
•             Excel sheet for entering, scoring and tracking PAM survey responses.  This sheet 
automatically calculates PAM scores and levels. 
  
Let me know if you have any questions.  We look forward to seeing your final paper as well as 
the outcome data of your research. 
  
Best regards, 
  
________________ 
Craig Swanson 
  
(612) 998 6216 
cswanson@insigniahealth.com 
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PAM 13 Question 
I. __ Whe __ • _• _ll i_s_sa_id_a_n_d_done __ ._l am __ lhe_ pet_ son_ v.i>o __ ;•_•eopon __ s_ibl_e_ro_r_ta_ki_·ng_ ca_r_e_or_m_y_he_ aJ_Ih _____ _ T a.k.ing an active role in rrry own health care is the most important thing that affects my health 
I am oonfident I can help prevent Of reduoe problems associated Yo'ith my health 
I know what each of my prescribed medications do 
I am oonr.dent that 1 can tell whether I need to go to the doctor 01 whether 1 can take cate of a health 
problem mysetr. 
I am conftdent that I can tell a doctor concerns I ha·re even 'Ihlen he 01' she does not ask. 
lam oooflldent that I can follow through on me<fteallreatments I may need to do at home 
I understand my heatth problems and what causes them. 
1 kooN what treatments are available for my health prob1em$ 
1 haY$ been able to maintain (keep up with) life:styl$ Cha"9es.like eatins right Of' exercising 
1 kni>'N how to prevent pcobJems with my health 
I am confdent t can figure out solutions when oew :lf'obSems arise with my health. 
I am confident that I can maintain lifestyle chai)Qes, like eating right and exercising. even during times of 
stress. 
*Related instruments: PAM 10, PAM 2, Clinician PAM 
Disengaged and 
overwhelmed 
lnd vid~ol; ore o.:ssivc 
ond l~ck cont ideno:e. 
Knowledge is lwt. 
goal·orientction is 
1/ltert< . .=:nd ;.dh~r?.nn:: i"i 
poor. Their p?rspecti,e: 
"My doct:>r is in :harge 
of,.~ he~lth • 
/./"---....."' 
\ 15-25% ) 
,_/ 
• 
'Level 2 
Becoming aware, but 
still struggling 
lnd i~iduals hove some 
knov.' edg~. but l~rge 
ga:>s remcin. They 
be i?ve h2alth is larg~ly 
nul of th::!i l (nntrd, but 
c:an set sirnpl~ goals. 
-h~i r per;pective: " I 
could be doing more." 
6 0 I u:-.Jvutstn of OREGox 
• 
' Level3 
Taking action 
lndividJols h.;vc the key 
·act5 a1d or? building 
self -mana;Jement sk Is. 
n,ey strive for best 
prttr:irP. h~l tilvinr~. nrd 
are goal-criented. Their 
persp~ctive: • ·m part of 
my ~ealth ca•e team. " 
Maintaining behaviors 
and pu~hing furthGt 
lndtvij~.; ls ha'JO adopted 
new be~ avbr>. but m~y 
struggle i1li01es of 
stress or change. 
Miiimr:~inin(J n h~rllllly 
lifest~l~ is a key foccs. 
Their perspecti•Je: 'Trr 
my own advocate • 
) 
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Appendix G 
My name is Anna Parton. I am a doctoral student in the Loretto Heights School of 
Nursing at Regis University, Denver, Colorado. My contact information is: 8116 Golden Eagle 
Road, Ft. Collins, Colorado; 972-922-7123. I am conducting a research study entitled "A 
Multiple Sclerosis Education Module to Improve Patient Activation and Self-Efficacy" which 
seeks to determine the value of education on MS patients' ability to care for their chronic 
disease. 
I am asking you to participate in this study because you have previously participated in 
other activities which have enhanced your knowledge ofMS or your ability to care for your 
disease process. Your participation is voluntary. Choosing not to participate will not affect your 
access to any goods or services. There are no direct benefits to participating in the study. 
I will be conducting the study by asking you to answer multiple choice question 
regarding your knowledge of multiple sclerosis and your involvement in your care. Participation 
in this study will take approximately 8 hours of your time, 2 hours on four separate dates. There 
will be no cost to participants. 
I will not be collecting any data that can link you to the answers you provide. Your 
anonymity and the confidentiality of your responses will be protected as much as possible. If 
you are uncomfortable answering any question, you may choose to not answer that question or to 
stop your participation and have any notes, recordings, or hard copy answers destroyed. To 
further protect the confidentiality of your responses, I will not be collecting a signed consent 
form but will instead consider your participation in the study as consent permitting me to collect 
the data you provide. 
Should you have any questions or concerns about participation in this study, you may 
contact me using the information in the first paragraph. My faculty Advisor is Dr. Colleen 
McCallum, email: cmccallum@regis.edu; phone: 303-964-6498.) You may also contact the 
Chair of the Regis University Institutional Review Board for human subjects participation by 
telephone at 303-346-4206; by mail at Regis University, Office of Academic Grants, 
447 Main, Mail Code H-4, 3333 Regis Blvd., Denver, CO, 80221; or by e-mail at 
irb@regis .edu with questions or concerns, or if you feel that participation in this 
study has resulted in some harm. 
Sincerely, 
~~~.P. L 
Anna C. Parton, RN, NP-C 
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Appendix H 
A Multiple Sclerosis Education Module to Promote Patient Activation and Efficacy 
I.  Session One 
 A.  Introduction and brief overview of DNP research protocol 
 B. Pre-test (Patient Activation Measure (PAM) and Multiple Sclerosis Knowledge 
     Questionnaire (MSKQ) 
 C. Definition of MS 
       1. Immune system 
     2. Inflammatory process 
 3. Demyelination  
 D. What Causes MS (epidemiology) 
 1. Genetics 
 2. Environmental Risk Factors 
 3. Geography    
E. What Happens in MS  
 1.  Immune system/Blood Brain Barrier 
 2.  Inflammatory process 
 3.  B cells and T cells 
 4.  Demyelination 
F. How is MS Diagnosed  
 1.  Clinical event 
 2.  MRI 
 3.  Lumbar puncture 
 4. Evoked potential 
 5.  McDonald Criteria 
 G. Clinical Overview (symptoms as related to location of lesions) 
 1. Sensory 
 2. Visual and hearing 
 3. Fatigue 
 4. Impaired mobility (spasticity, ataxia, vertigo) 
 5. Bowel and bladder 
 6. Dysphagia  
 7. Cognitive dysfunction 
 8. Mood dysregulation 
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II. Session Two: 
A. Early diagnosis/Early treatment 
1. Decrease exacerbation 
2. Delay disability 
  B.  Treatment choices (informed decision) 
  1.  Avonex/Plegridy 
  2.  Betaseron/Extavia 
  3.  Copaxone 
  4.   Rebif 
  5.  Tysabri 
  6.  Novantrone 
  7.  Gilenya 
  8. Aubagio 
  9. Tecfidera 
  10. Lemtrada 
 
III. Session Three 
A.  Clinical Features and Symptom Management 
 1.  Sensory 
 2.  Visual and hearing 
 3.  Fatigue 
 4.  Impaired mobility (spasticity, ataxia, vertigo) 
 5.  Bowel and bladder 
 6.  Dysphagia  
 7.  Cognitive dysfunction 
 8.  Mood dysregulation 
B. Alternative treatment thoughts 
C.  Disclosure 
 1. Family 
 2. Friends 
 3. Employer  
  
IV. Session Four 
A. Self-Efficacy and Patient Activation 
B. Patient Responsibility 
C. Working with Your Doctor 
D. Cost Containment for Chronic Disease 
E. Affordable Care Act 
 
